November 21, 2024
Tag: Ned Sharpless
October 23, 2024
HemOnc Today: Cancer research in US increasingly dominated by industry sponsors
October 10, 2024
MedPage Today: Let’s Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?
October 7, 2024
A call to bridge the gap in cancer clinical trial funding
In a Journal of Clinical Oncology editorial, Yara Abdou, MD, and Norman E. Sharpless, MD, share their concerns about a growing reliance on industry-sponsored cancer clinical trials in the U.S.
January 9, 2024
Sharpless appointed to American Cancer Society board
The American Cancer Society named UNC Lineberger’s Norman “Ned” Sharpless, MD, to its board of directors.
May 23, 2023
Scientific retreat underscores impact and promise of cancer center’s research
UNC Lineberger's annual scientific retreat brought together faculty, staff and trainees to learn about the latest research at the cancer center.
May 4, 2023
New York Times: Link Between Long Telomeres and Long Life Is a Tall Tale, Study Finds
February 18, 2023
Healio: Former NCI director: Obesity-related cancers, ‘pandemic hangover’ are major challenges
October 26, 2022
Postdoc-Faculty Research Day features more than 60 presentations, talk by former NCI Director Ned Sharpless
UNC Lineberger’s 47th annual Postdoc-Faculty Research Day provided an opportunity for cancer center trainees to present their scientific findings to an audience of peers and faculty.
October 17, 2022
Sharpless elected to the National Academy of Medicine
Norman E. “Ned” Sharpless, MD, was recognized for his significant contributions to help advance the understanding of cellular aging, circular RNAs and the cell cycle.